FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Innova Captab IPO is a book built issue of Rs 570.00 crores. The issue is a combination of fresh issue of 0.71 crore shares aggregating to Rs 320.00 crores and offer for sale of 0.56 crore shares aggregating to Rs 250.00 crores.
Innova Captab IPO bidding started from December 21, 2023 and ended on December 26, 2023. The allotment for Innova Captab IPO was finalized on Wednesday, December 27, 2023. The shares got listed on BSE, NSE on December 29, 2023.
Innova Captab IPO price band is set at ₹426 to ₹448 per share. The minimum lot size for an application is 33 Shares. The minimum amount of investment required by retail investors is ₹14,784. The minimum lot size investment for sNII is 14 lots (462 shares), amounting to ₹206,976, and for bNII, it is 68 lots (2,244 shares), amounting to ₹1,005,312.
ICICI Securities Limited and Jm Financial Limited are the book running lead managers of the Innova Captab IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Innova Captab IPO RHP for detailed information.
IPO Date | December 21, 2023 to December 26, 2023 |
Listing Date | December 29, 2023 |
Face Value | ₹10 per share |
Price Band | ₹426 to ₹448 per share |
Lot Size | 33 Shares |
Total Issue Size | 12,723,214 shares (aggregating up to ₹570.00 Cr) |
Fresh Issue | 7,142,857 shares (aggregating up to ₹320.00 Cr) |
Offer for Sale | 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share holding post issue | 57,224,929 |
Innova Captab IPO offers 12,723,213 shares. 2,544,643 (20.00%) to QIB, 1,908,482 (15.00%) to NII, 4,453,125 (35.00%) to RII and 3,816,963 (30.00%) to Anchor investors. 134,943 RIIs will receive minimum 33 shares and 1,376 (sNII) and 2,753 (bNII) will receive minimum 462 shares. (in case of oversubscription)
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | 3,816,963 (30.00%) | NA |
QIB Shares Offered | 2,544,643 (20.00%) | NA |
NII (HNI) Shares Offered | 1,908,482 (15.00%) | |
bNII > ₹10L | 1,272,322 (10.00%) | 2,753 |
sNII < ₹10L | 636,161 (5.00%) | 1,376 |
Retail Shares Offered | 4,453,125 (35.00%) | 134,943 |
Total Shares Offered | 12,723,213 (100%) |
Innova Captab IPO raises Rs 171.00 crore from anchor investors. Innova Captab IPO Anchor bid date is December 20, 2023. Innova Captab IPO Anchor Investors list
Bid Date | December 20, 2023 |
Shares Offered | 3,816,963 |
Anchor Portion Size (In Cr.) | 171.00 |
Anchor lock-in period end date for 50% shares (30 Days) | January 26, 2024 |
Anchor lock-in period end date for remaining shares (90 Days) | March 26, 2024 |
Innova Captab IPO opens on December 21, 2023, and closes on December 26, 2023.
IPO Open Date | Thursday, December 21, 2023 |
IPO Close Date | Tuesday, December 26, 2023 |
Basis of Allotment | Wednesday, December 27, 2023 |
Initiation of Refunds | Thursday, December 28, 2023 |
Credit of Shares to Demat | Thursday, December 28, 2023 |
Listing Date | Friday, December 29, 2023 |
Cut-off time for UPI mandate confirmation | 5 PM on December 26, 2023 |
Investors can bid for a minimum of 33 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 33 | ₹14,784 |
Retail (Max) | 13 | 429 | ₹192,192 |
S-HNI (Min) | 14 | 462 | ₹206,976 |
S-HNI (Max) | 67 | 2,211 | ₹990,528 |
B-HNI (Min) | 68 | 2,244 | ₹1,005,312 |
Lot Size Calculator |
The Promoters of the company, namely Manoj Kumar Lohariwala and Vinay Kumar Lohariwala
Share Holding Pre Issue | 66.85% |
Share Holding Post Issue |
Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.
The company's product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines.
In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company's own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.
As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company's manufacturing facility is located in Buddi, Haryana
The company's customer base includes Cipla, Glenmark Pharmaceuticals, Wockhardt, Corona Remedies, Emcure Pharmaceuticals, Lupin, Medley Pharmaceuticals, Eris Healthcare, Zuventus Healthcare, Ajanta Pharma, Mankind Pharma, and others.
As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.
Innova Captab Limited's revenue increased by 16.45% and profit after tax (PAT) rose by 6.26% between the financial year ending with March 31, 2023 and March 31, 2022.
Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
Assets | 1,086.16 | 704.41 | 575.48 | 369.62 |
Revenue | 234.37 | 935.58 | 803.41 | 412.03 |
Profit After Tax | 17.59 | 67.95 | 63.95 | 34.50 |
Net Worth | 294.27 | 276.46 | 208.56 | 144.78 |
Reserves and Surplus | 317.51 | 228.51 | 196.61 | 132.82 |
Total Borrowing | 441.90 | 235.19 | 198.18 | 45.03 |
Amount in ₹ Crore |
The market capitalization of Innova Captab IPO is Rs 2563.7 Cr.
KPI | Values |
---|---|
ROE | 24.58% |
ROCE | 22.61% |
Debt/Equity | 0.85 |
RoNW | 24.58% |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 14.16 | |
P/E (x) | 31.64 | 36.42 |
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
[Dilip Davda] The company is a branded generic pharmaceutical products manufacturer for the domestic and international markets. It has posted growth in its top and bottom lines. Recent acquisition of Sharon Bio by the company augurs well for its synergistic growth plans. It is also gearing for new product portfolio with its upcoming new plant at Jammu. Based on FY24 annualized earnings, the issue appears fully priced, but it is poised for bright prospects post expansion. Investors may park funds for the medium to long term rewards. Read detail review...
The Innova Captab IPO is subscribed 55.26 times on December 26, 2023 6:07:00 PM. The public issue subscribed 17.15 times in the retail category, 116.73 times in the QIB category, and 64.95 times in the NII category. Check Day by Day Subscription Details (Live Status)
Category | Subscription (times) |
---|---|
QIB | 116.73 |
NII | 64.95 |
bNII (bids above ₹10L) | 71.59 |
sNII (bids below ₹10L) | 51.65 |
Retail | 17.15 |
Total | 55.26 |
Total Application : 2,392,538 (17.73 times)
Listing Date | December 29, 2023 |
BSE Script Code | 544067 |
NSE Symbol | INNOVACAP |
ISIN | INE0DUT01020 |
Final Issue Price | ₹448 per share |
Price Details |
---|
Final Issue Price |
Open |
Low |
High |
Last Trade |
BSE |
---|
₹448.00 |
₹456.10 |
₹452.00 |
₹547.30 |
₹545.15 |
NSE |
---|
₹448.00 |
₹452.10 |
₹452.10 |
₹542.50 |
₹541.40 |
Innova Captab Limited
601, Proxima,
Plot No. 19, Sector
30 A, Vashi, Navi Mumbai, 400 705
Phone: +91 22 2564 2095
Email: investors@innovacaptab.com
Website: https://www.innovacaptab.com/
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: innovacaptab.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Innova Captab IPO is a main-board IPO of 12,723,214 equity shares of the face value of ₹10 aggregating up to ₹570.00 Crores. The issue is priced at ₹426 to ₹448 per share. The minimum order quantity is 33 Shares.
The IPO opens on December 21, 2023, and closes on December 26, 2023.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Innova Captab IPO using UPI as a payment gateway. Zerodha customers can apply in Innova Captab IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Innova Captab IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Innova Captab IPO opens on December 21, 2023 and closes on December 26, 2023.
Innova Captab IPO lot size is 33 Shares, and the minimum amount required is ₹14,784.
You can apply in Innova Captab IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Innova Captab IPO will be done on Wednesday, December 27, 2023, and the allotted shares will be credited to your demat account by Thursday, December 28, 2023. Check the Innova Captab IPO allotment status.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
Top Contributor (800+ Posts, 200+ Likes)